$AIDX
20/20 Biolabs, Inc. Common Stock
XNAS•Industrials•Services-Testing Laboratories
$0.400
▲+5.54%+$0.021
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonate20/20 Biolabs, Inc. Common Stock
XNAS•Industrials•Services-Testing Laboratories
Why is AIDX up today? It is at $0.400 (+5.54%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AIDX spikes, and full due diligence on AIDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AIDX 2 times in the last 30 days. Create a free account to track $AIDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AIDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AIDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from an SEC filing. Read it →Latest filingPRE 14APreliminary proxy statementOct 7, 2026 · 4 days agoAcross every filing on file, supply equal to 124% of the tradeable float is in play - 124% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
15,164,724 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cohen Richard M Director | Acquired (grant/award) | +8K 0.06% of company | n/a | 8K | n/a | Feb 19, 26 |
Compton John G. Director | Acquired (grant/award) | +8K 0.06% of company | added 100% | 14K | n/a | Feb 19, 26 |
Ross Michael A. Director | Acquired (grant/award) | +31 | n/a | 31 | n/a | Feb 19, 26 |
Rollins John Woodson Director | Acquired (grant/award) | +19K 0.2% of company | added 100% | 30K | n/a | Feb 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-testing laboratories, closest in size first.
Here is the latest on AIDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AIDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AIDX last traded at $0.400, up 5.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
20/20 Biolabs, Inc. Common Stock (AIDX) is next expected to report earnings on Friday, November 13, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AIDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AIDX 2 times in the last 30 days.
AIDX (20/20 Biolabs, Inc. Common Stock) trades on XNAS, with a market cap of about $5M in the Services-Testing Laboratories sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AIDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AIDX discussion
Sign in to ask a question or join the discussion.